Assessment of Vitamin E Concentrations in Serum and Cerebrospinal Fluid of Horses Following Oral Administration of Vitamin E
Overview
Affiliations
Objective: To determine concentrations of alpha-tocopherol in serum and CSF of healthy horses following administration of supplemental vitamin E in feed.
Animals: 10 healthy adult horses.
Procedures: Horses were allocated to receive supplemental d-alpha-tocopherol (1,000 U/d [group A; n=5] or 10,000 U/d [group B; 5]) in feed for 10 days. Blood samples were collected before (baseline), during, and at intervals for 10 days after discontinuation of vitamin E administration for assessment of serum alpha-tocopherol concentration. Cerebrospinal fluid samples were collected prior to and 24 hours after cessation of vitamin E administration. Alpha-tocopherol concentrations in serum and CSF samples were analyzed via high-performance liquid chromatography; changes in those values during the treatment period were compared between groups, and the relationship of serum and CSF alpha-tocopherol concentrations was evaluated.
Results: In both groups, serum alpha-tocopherol concentration increased significantly from baseline during vitamin E administration; values in group B were significantly greater than those in group A during and after treatment. At the end of vitamin E administration, CSF alpha-tocopherol concentration was not significantly greater than the baseline value in either group; however, the increase in CSF concentration was significant when the group data were combined and analyzed. Serum and CSF alpha-tocopherol concentrations were significantly correlated at baseline for all horses, but were not strongly correlated after 10 days of vitamin E administration.
Conclusions And Clinical Relevance: In healthy horses, daily oral administration of supplemental vitamin E in feed resulted in increases in serum and CSF alpha-tocopherol concentrations.
Increased α-tocopherol metabolism in horses with equine neuroaxonal dystrophy.
Hales E, Habib H, Favro G, Katzman S, Sakai R, Marquardt S J Vet Intern Med. 2021; 35(5):2473-2485.
PMID: 34331715 PMC: 8478026. DOI: 10.1111/jvim.16233.
Veterinary Pet Supplements and Nutraceuticals.
Finno C Nutr Today. 2021; 55(2):97-101.
PMID: 33446942 PMC: 7802882. DOI: 10.1097/nt.0000000000000399.
Equine degenerative myeloencephalopathy: prevalence, impact, and management.
Burns E, Finno C Vet Med (Auckl). 2018; 9:63-67.
PMID: 30234005 PMC: 6135079. DOI: 10.2147/VMRR.S148542.
Finno C, Bordbari M, Gianino G, Ming-Whitfield B, Burns E, Merkel J Free Radic Biol Med. 2018; 120:289-302.
PMID: 29526809 PMC: 5940542. DOI: 10.1016/j.freeradbiomed.2018.02.037.
Brown J, Valberg S, Hogg M, Finno C Equine Vet J. 2017; 49(6):753-758.
PMID: 28432750 PMC: 5640495. DOI: 10.1111/evj.12692.